Supplementary Appendix: Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients with Diabetes Mellitus: New Insights from CANVAS

Published: 16 May 2023| Version 1 | DOI: 10.17632/sxs4ybcfh3.1
Contributors:
,
,
,
, Fahim Ebrahimi

Description

This supplementary appendix has been provided by the authors to give readers additional information about their work. Supplement to: Borisov A. et al. Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients with Diabetes Mellitus: New Insights from CANVAS. This study, carried out under YODA Project # 2020-4409, used data obtained from the Yale University Open Data Access Project, which has an agreement with JANSSEN RESEARCH & DEVELOPMENT, L.L.C.. The interpretation and reporting of research using this data are solely the responsibility of the authors and does not necessarily represent the official views of the Yale University Open Data Access Project or JANSSEN RESEARCH & DEVELOPMENT, L.L.C.

Files

Institutions

Universitatsspital Basel, Clarunis Universitares Bauchzentrum Basel, Kantonsspital Aarau

Categories

Liver, Non-Alcoholic Fatty Liver Disease, Diabetes Mellitus, Metabolic Syndrome

Funding

Swiss National Science Foundation

P500PM_210866

Licence